{"id":"W2963723783","doi":"10.1136/esmoopen-2019-000532","title":"A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"ESMO Open","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche","keywords":"Carboplatin; Paclitaxel; Lung cancer; Medicine; Oncology; Internal medicine; Cancer research; Chemotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001030634,0.001010562,0.001894337,0.0003669259,0.0003484089,0.0008078357,0.0007081429,0.0009433024,0.00245407],"category_scores_gemma":[0.0005484262,0.0004477006,0.001004049,0.0003562186,0.0007826653,0.0005267597,0.0002232509,0.001869268,0.0005330505],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008067556,"about_ca_system_score_gemma":0.001258312,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007724506,"about_ca_topic_score_gemma":0.002594142,"domain_scores_codex":[0.9996824,0.0001596269,0.00001615073,0.00005239437,0.00002545124,0.00006383655],"domain_scores_gemma":[0.9996548,0.00004600655,0.00006758378,0.00002971346,0.00002147635,0.0001804449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6286085,0.0965369,0.01341745,0.001409249,0.001804784,0.0005450509,0.0004433194,0.003047767,0.1297149,0.00020589,0.002349985,0.1219164],"study_design_scores_gemma":[0.4399993,0.5283896,0.01685028,0.00004181571,0.0006935507,0.000529649,0.00008017878,0.00130136,0.009919502,0.00009427639,0.00207562,0.00002479626],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950295,0.001821064,0.0003695657,0.0001759291,0.00006082771,0.001501015,0.0002689745,0.00005304839,0.0007201159],"genre_scores_gemma":[0.9934639,0.001433109,0.001104768,0.0004038737,0.0001033143,0.001140655,0.001005411,0.00002106592,0.001323919],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00245407,"threshold_uncertainty_score":0.008209705,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02520585020919555,"score_gpt":0.3661034264544797,"score_spread":0.3408975762452842,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}